Tuesday, October 25, 2011

A new treatment strategy for Alzheimer's patients
(estrogen receptors)
Please Help Support Alzheimer's Research Today! 
Your Alzheimer's donation will help billions live without it.
DONATE NOW\
A study from University of Houston recommends a different approach in developing drugs to treat Alzheimer’s, cancer, multiple sclerosis, and other cardiovascular diseases. Scientists from the Center for Nuclear Receptors and Cell Signaling (CNRCS) at UH are finalizing the results of their study that was conducted in 1996, according to an interview was published on Nature Reviews Drug Discovery magazine for their October issue. This extensive study, about the Estrogen Beta receptors, was led by Dr. Jan-Åke Gustafsson, UH professor and CNRCS director, and an expert when it comes to estrogen receptors. He is known for the discovery of Estrogen Beta Receptors during his tenure at the Karolina institute in Stockholm, Sweden.

"We have known for some time that female sex hormones – estrogens – influence a number of functions in the human body," said Gustafsson to Eurek Alert.
"Only recently have we and others found that one of the estrogen receptors – ERβ – is a potential target for the treatment of Alzheimer's and other chronic diseases.. Continue to readibtimes.com

Garcinia use in weight loss supplements questioned

Although some clinical trials have shown Garcinia extract to aid short term weight loss, the overall evidence suggests that supplements are “not as effective as conventional weight loss pills,” says a new systematic review. Read morenutraingredients.com
Get Energy Active!
Погода в Беларуси

Posted YVN (AMYLOID @ PHOTO)

No comments:

Post a Comment